Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia

被引:153
|
作者
Pavoni, Vittorio [1 ,2 ]
Gianesello, Lara [3 ]
Pazzi, Maddalena [1 ,2 ]
Stera, Caterina [1 ,2 ]
Meconi, Tommaso [1 ,2 ]
Frigieri, Francesca Covani [1 ,2 ]
机构
[1] Santa Maria Annunziata Hosp, Emergency Dept, Florence, Italy
[2] Santa Maria Annunziata Hosp, Crit Care Area, Anesthesia & Intens Care Unit, Florence, Italy
[3] Univ Hosp Careggi, Dept Anesthesia & Intens Care, Orthoped Anesthesia, Florence, Italy
关键词
SEVERE SEPSIS; COAGULOPATHY; HEMOSTASIS; MANAGEMENT;
D O I
10.1007/s11239-020-02130-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Critically ill patients with COVID-19 pneumonia suffered both high thrombotic and bleeding risk. The effect of SARS-CoV-2 on coagulation and fibrinolysis is not well known. We conducted a retrospective study of critically ill patients admitted to an intensive care unit (ICU) a cause of severe COVID-19 pneumonia and we evaluated coagulation function using rotational thromboelastometry (ROTEM) on day of admission (T0) and 5 (T5) and 10 (T10) days after admission to ICU. Coagulation standard parameters were also evaluated. Forty patients were enrolled into the study. The ICU and the hospital mortality were 10% and 12.5%, respectively. On ICU admission, prothrombin time was slightly reduced and it increased significantly at T10 (T0 = 65.1 +/- 9.8 vs T10 = 85.7 +/- 1.5, p = 0.002), while activated partial thromboplastin time and fibrinogen values were higher at T0 than T10 (32.2 +/- 2.9 vs 27.2 +/- 2.1, p = 0.017 and 895.1 +/- 110 vs 332.5 +/- 50, p = 0.002, respectively); moreover, whole blood thromboelastometry profiles were consistent with hypercoagulability characterized by an acceleration of the propagation phase of blood clot formation [i.e., CFT below the lower limit in INTEM 16/40 patients (40%) and EXTEM 20/40 patients (50%)] and significant higher clot strength [MCF above the upper limit in INTEM 20/40 patients (50%), in EXTEM 28/40 patients (70%) and in FIBTEM 29/40 patients (72.5%)]; however, this hypercoagulable state persists in the first five days, but it decreases ten day after, without returning to normal values. No sign of secondary hyperfibrinolysis or sepsis induced coagulopathy (SIC) were found during the study period. In six patients (15%) a deep vein thrombosis and in 2 patients (5%) a thromboembolic event, were found; 12 patients (30%) had a catheter-related thrombosis. ROTEM analysis confirms that patients with severe COVID-19 pneumonia had a hypercoagulation state that persisted over time.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 50 条
  • [21] Coinfection and superinfection in ICU critically ill patients with severe COVID-19 pneumonia and influenza pneumonia: are the pictures different?
    Chen, Ziying
    Zhan, Qingyuan
    Huang, Linna
    Wang, Chen
    [J]. FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [22] Severe neurological complications in critically ill COVID-19 patients
    Notz, Quirin
    Lotz, Christopher
    Herrmann, Johannes
    Vogt, Marius
    Schlesinger, Tobias
    Kredel, Markus
    Muellges, Wolfgang
    Weismann, Dirk
    Westermaier, Thomas
    Meybohm, Patrick
    Kranke, Peter
    [J]. JOURNAL OF NEUROLOGY, 2021, 268 (05) : 1576 - 1579
  • [23] A Vicious Cycle: In Severe and Critically Ill COVID-19 Patients
    Huang, Peifeng
    Zuo, Qingwei
    Li, Yue
    Oduro, Patrick Kwabena
    Tan, Fengxian
    Wang, Yuanyuan
    Liu, Xiaohui
    Li, Jing
    Wang, Qilong
    Guo, Fei
    Yang, Long
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] Severe neurological complications in critically ill COVID-19 patients
    Quirin Notz
    Christopher Lotz
    Johannes Herrmann
    Marius Vogt
    Tobias Schlesinger
    Markus Kredel
    Wolfgang Muellges
    Dirk Weismann
    Thomas Westermaier
    Patrick Meybohm
    Peter Kranke
    [J]. Journal of Neurology, 2021, 268 : 1576 - 1579
  • [25] Severe Liver Dysfunction in critically ill Patients with COVID-19
    Roedl, K.
    Jarczak, D.
    Drolz, A.
    Wichmann, D.
    de Heer, G.
    Burdelski, C.
    Nierhaus, A.
    Luetgehetmann, M.
    Kluge, S.
    Fuhrmann, V.
    [J]. MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2021, 116 (SUPPL 2) : 68 - 68
  • [26] A comprehensive assessment of the coagulation profile in critically ill COVID-19 patients
    Adam, E. H.
    Zacharowski, K.
    Miesbach, W.
    [J]. THROMBOSIS RESEARCH, 2020, 194 : 42 - 44
  • [27] Ventilator-associated pneumonia in critically ill patients with COVID-19
    Maes, Mailis
    Higginson, Ellen
    Pereira-Dias, Joana
    Curran, Martin D.
    Parmar, Surendra
    Khokhar, Fahad
    Cuchet-Lourenco, Delphine
    Lux, Janine
    Sharma-Hajela, Sapna
    Ravenhill, Benjamin
    Hamed, Islam
    Heales, Laura
    Mahroof, Razeen
    Solderholm, Amelia
    Forrest, Sally
    Sridhar, Sushmita
    Brown, Nicholas M.
    Baker, Stephen
    Navapurkar, Vilas
    Dougan, Gordon
    Scott, Josefin Bartholdson
    Morris, Andrew Conway
    [J]. CRITICAL CARE, 2021, 25 (01)
  • [28] Camostat mesylate therapy in critically ill patients with COVID-19 pneumonia
    Sakr, Yasser
    Bensasi, Hatim
    Taha, Ahmed
    Bauer, Michael
    Ismail, Khaled
    [J]. INTENSIVE CARE MEDICINE, 2021, 47 (06) : 707 - 709
  • [29] Camostat mesylate therapy in critically ill patients with COVID-19 pneumonia
    Yasser Sakr
    Hatim Bensasi
    Ahmed Taha
    Michael Bauer
    Khaled Ismail
    [J]. Intensive Care Medicine, 2021, 47 : 707 - 709
  • [30] The Effectiveness of Bevacizumab in COVID-19 Pneumonia Among Critically Ill Patients
    Rajachandran, Karthikkeyan
    Varghese, Giphy Susan
    Kumar, J. Vinoth
    Raja, Santhosh
    Chandran, S. K. Jagadish
    Aruloli, M.
    Murali, A.
    [J]. EGYPTIAN JOURNAL OF CRITICAL CARE MEDICINE, 2022, 9 (03): : 79 - 84